Capital Flow Monitor · Sponsors · CIK 1812786
Molecule Ventures LP
860 BROADWAY, NEW YORK, NY, 10003 · 929-448-8031
Pooled Investment Fund / Other Investment Fund · Limited Partnership· inc. DELAWARE true
Fit score
—
Offering
—
Sold
$329.2M
% sold
—
Investors
128
Min investment
$100K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | D/A ·current | 506(b) | — | $329.2M | — | 128 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Nikhil Mittal — Director, New York, NY
3 other raises
- Molecule UK Carbon II LP $5.0M of —
- MV Global Carbon Fund LP $96.1M of —
- BlueRidge Ventures, a Series of Decile Start Fund, LP $155K of $155K · 100.0%
-
Nicholas Kracov — Director, New York, NY
2 other raises
- Molecule UK Carbon II LP $5.0M of —
- MV Global Carbon Fund LP $96.1M of —
-
Gary Claar — Director, New York, NY
2 other raises
- Molecule UK Carbon II LP $5.0M of —
- MV Global Carbon Fund LP $96.1M of —
Placement agents
- Jesse Richmand · 0 RE raises
- Avraham Shmuel Sage · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.